During the past decade, Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 6 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 10 trials, followed by "Gruppo Italiano Trapianto di Midollo Osseo" with 6 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored and "Alexion" with 4 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Associazione Italiana per la Ricerca sul Cancro" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia" are "Chronic Lymphocytic Leukemia" (3 trials), "Diffuse Large B-Cell Lymphoma" (2 trials), "Hematologic Diseases" (2 trials), "Hemoglobinuria, Paroxysmal" (2 trials) and "Non-Hodgkin's Lymphoma" (2 trials). Many other conditions were trialed in "Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia" in a lesser frequency.

Most popular intervention types in "Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia" are "Drug" (25 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "Venetoclax" (3 trials), "eculizumab" (3 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia". 1 are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".